Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass ofDisodium [1-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN1}naphthalen-2-olato(2-)-kO][3-(hydroxy-kO)-4-{[2-(hydroxy-kO)naphthalen-1-yl]diazenyl-kN1}-7-nitronaphthalene-1-sulfonato(3-)]chromate(2-) andDisodium [1-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN2}naphthalen-2-olato(2-)-kO][3-(hydroxy-kO)-4-{[2-(hydroxy-kO)naphthalen-1-yl]diazenyl-kN1}-7-nitronaphthalene-1-sulfonato(3-)]chromate(2-)
EC number: 944-038-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Study initiation date: 08 March, 1993; Experiment start date - 19 March, 1993; Experiment end date - 04 May, 1993; Study completion date: 28 June, 1993.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- a statistical analysis was not performed as no appropriate statistical method is available.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5265 (The Salmonella typhimurium Bacterial Reverse Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Disodium [1-[(2-hydroxy-3,5-dinitrophenyl)azo]-2-naphtholato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- EC Number:
- 274-487-5
- EC Name:
- Disodium [1-[(2-hydroxy-3,5-dinitrophenyl)azo]-2-naphtholato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Cas Number:
- 70236-55-4
- Molecular formula:
- C36H18CrN7O13S.2Na
- IUPAC Name:
- disodium [1-[(2-hydroxy-3,5-dinitrophenyl)azo]-2-naphtholato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Identification of the test material as used in the study report: Irgalan Schwarz BGL Roh Trocken (FAT 20037/C)
- Source and batch No.of test material: 9300001
- Expiration date of the lot/batch: February 1998
OTHER SPECIFICS:
- Purity: about 80 %
Method
- Target gene:
- Histidine requiring genes of Salmonella strains
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: histidine-auxotrophic strains obtained from Prof. B. Ames, Berkeley, CA., U.S.A.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat-liver microsomal fraction S9 was prepared in advance from male RAI rats (Tif: RAIf[SPF]), reared at the Animal Farm of CIBA GEIGY, Sisseln, Switzerland. The animals (150-250 g) were treated with Aroclor 1254 (500 mg/kg, i.p.) 5 days prior to sacrifice. The livers were homogenized with 3 volumes of 150 mM KCl and the 9000x g supernatant (S9) was stored at approximately -80 °C for no longer than one year. The protein contents of the S9 fractions were 29.4 and 30.6 mg/ml.
- Test concentrations with justification for top dose:
- Experiment without metabolic activation: 61.7, 185.2, 555.6, 1666.7 & 5000 µg/plate;
Experiment with metabolic activation: 61.7, 185.2, 555.6, 1666.7 & 5000 µg/plate; - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethylsulfoxide (Suspension)
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- Without microsomal activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- Without microsomal activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-nitrofluorene
- Remarks:
- Without microsomal activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2- aminoanthracene
- Remarks:
- With metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- With metabolic activation
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: Triplicate
- Number of independent experiments : Two
METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in medium; in agar (plate incorporation).
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: Background growth inhibition.
METHODS FOR MEASUREMENTS OF GENOTOXICIY : increase of the mean number of revertants per plate above that of the negative control. - Evaluation criteria:
- Assay acceptance criteria:
A test was considered acceptable if the mean colony counts of the control values of all strains were within the acceptable ranges and if the results of the positive controls met the criteria for a positive response. In either case the final decision was based on the scientific judgement of the Study Director.
Criteria for a positive response:
The test substance was considered to be mutagenic in this test system if the following conditions are met:
At least a reproducible meaningful increase of the mean number of revertants per plate above that of the negative control at any concentration for one or more of the following strains: S. typhimurium TA 98, TA 100, TA 102, TA 1535 and TA 1537.
Generally a concentration-related effect should be demonstrable. - Statistics:
- In deviation to the OECD guideline, a statistical analysis was not performed as no appropriate statistical method is available.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- other: Salmonella typhimurium TA 98, TA 100 and TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In the mutagenicity tests without and with metabolic activation, due to toxicity of the test material, a slight decline in the number of revertant colonies was occasionally observed with all strains at the highest concentrations.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In the mutagenicity tests without and with metabolic activation, due to toxicity of the test material, a slight decline in the number of revertant colonies was occasionally observed with all strains at the highest concentrations.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In the mutagenicity tests without and with metabolic activation, due to toxicity of the test material, a slight decline in the number of revertant colonies was occasionally observed with all strains at the highest concentrations.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
Six concentrations of FAT 20037/C ranging from 20.6 to 5000 µg/plate were tested with strain S. typhimurium TA 100 to determine the highest concentration to be used in the mutagenicity assay. The experiments were performed with and without microsomal activation. The numbers of revertant colonies were markedly increased at the upper concentrations. From the results obtained, the highest concentration suitable for the mutagenicity test was selected to be 5000 µg/plate without and with activation.
Any other information on results incl. tables
Mutagenicity test, original experiment
In the original experiment performed without metabolic activation, treatment of strain TA 100 with FAT 20037/C led to a moderate, concentration dependent increase in the number of revertant counts at the concentrations of 185.2 to 1666.7 µg/plate. With strain TA 1535 a very weak increase in the number of back-mutants was observed at the concentrations of 1666.7 and 5000 µg/plate. With strain TA 98 a strong, concentration dependent increase in the number of backmutants was observed at all concentrations. With strain TA 1537 a moderate increase in the number of revertants was registered at the concentrations of 61.7 to 555.6 µg/plate. No effect was seen with strain TA 102.
In the original experiment performed with activation, treatment of strain TA 100 with FAT 20037/C led to a moderate, concentration dependent increase in the number of revertant counts at the concentrations of 185.2 to 1666.7 µg/plate. With strain TA 1535 a very weak increase in the number of back-mutants was observed at the concentration of 555.6 µg/plate only. With strain TA 98 a strong, concentration dependent increase in the number of back-mutants was observed at the concentrations of 61.7 to 1666.7 µg/plate. With strain TA 1537 a moderate increase in the number of revertants was registered at the concentrations of 61.7 to 1666.7 µg/plate. No effect was seen with strain TA 102. In the experiment with activation performed on strain TA 102 the mean number of colony counts in the negative control was somewhat above the acceptable range given on page 19. This, however, does not affect the test results.
Mutagenicity test, confirmatory experiment
In the confirmatory experiment performed without metabolic activation, treatment of strain TA 100 with FAT 20037/C again led to a moderate, concentration dependent increase in the number of revertant counts at the concentrations of 185.2 to 1666.7 µg/plate. In the confirmatory experiment performed without metabolic activation, treatment of strain TA 100 with FAT 20037/C again led to a moderate, concentration dependent increase in the number of revertant counts at the concentrations of 185.2 to 1666.7 µg/plate. The effect observed in the original experiment with strain TA 1535 could not be reproduced. With strain TA 102 a very weak increase in the number of revertants was registerd at the concentration of 555.6 µg/plate. With strain TA 98 a strong, concentration dependent increase in the number of back-mutants was observed at the concentrations of 61.7 to 1666.7 µg/plate . With strain TA 1537 a moderate increase in the number of revertants was registered at the same concentrations.
In the confirmatory experiment performed with activation, treatment of strain TA 100 with FAT 20037/C again led to a moderate, concentration dependent increase in the number of revertant counts at the concentrations of 185.2 to 1666.7 µg/plate. With strain TA 1535 a very weak increase in the number of back-mutants was observed at the same concentrations of 185.2 to 5000 µg/plate. With strain TA 98 a strong, concentration dependent increase in the number of back-mutants was observed at the concentrations of 61.7 to 1666.7 µg/plate. With strain TA 1537 a moderate increase in the number of revertants was registered at all concentrations. No effect was seen with strain TA 102. In the mutagenicity tests without and with metabolic activation, due to a growth-inhibiting effect of the test material, a slight decline in the number of revertant colonies was occasionally observed with all strains at the highest concentrations.
Applicant's summary and conclusion
- Conclusions:
- FAT 20037/C exerted a clear-cut mutagenic action on strains S. typhimurium TA 98, TA 100 and TA 1537.
- Executive summary:
The mutagenic potential of the test item was investigated in a bacterial reverse mutation assay according to OECD guideline 471 and EU method B.13/14 in compliance with GLP.
Based on the results of a preliminary toxicity test, FAT 20037/C was tested for mutagenic effects without and with metabolic activation at five concentrations in the range of 61.7 to 5000 µg/plate. An independent repetition of the experiments was performed with the same concentrations.
In the original experiment performed without and with metabolic activation, after treatment of the bacterial cultures with FAT 20037/C, the number of revertant counts increased strongly with strain TA 98, moderately with strains TA 100 and TA 1537 and slightly with strain TA 1535. In the confimatory experiment performed without activation, after treatment of the bacterial cultures with FAT 20037/C the number of revertant counts again increased strongly with TA 98 and moderately with strains TA 100 and TA 1537. A very weak increase in the number of back-mutants occurred on strain TA 102. The effect observed in the original experiment with strain TA 1535 could not be reproduced. In the confirmatory experiment carried out with activation, a strong increase in the number of back-mutants occurred on strain TA 98, a moderate increase on strains TA 100 and TA 1537 and very weak one on strain TA 1535.
Based on the results of these experiments, it was concluded that FAT 20037/C exerted a clear-cut mutagenic action on strains S. typhimurium TA 98, TA 100 and TA 1537.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.